Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I-III Mucinous Colorectal Adenocarcinoma.
Yu-Cui LiaoHou-Qun YingYing HuangYan-Ran LuoCui-Fen XiongRuo-Wei NieXiao-Juan LiXue-Xin ChengPublished in: Cancer management and research (2021)
FPR is the preferred inflammatory biomarker and commonly used for predicting and monitoring recurrence in stage I-III MCA patients. The combined TNM-CA199-FPR score is an economical, simple, effective, and independent prognostic factor for localized disease.